Clear Labs, the new standard for molecular food quality, launched from stealth today and announced a $6.5m Series A financing round with participation from Khosla Ventures and Felicis Ventures, among other strategic investors. Clear Labs ...
Tags: Clear Labs, food, molecular, additives
AMSBIO has launched CancerSeq™ - a new range of genetically characterised FFPE tissue samples. CancerSeq™ samples are prepared from genomic DNA extracted from the FFPE tumour tissues and validated by Next Generation ...
Illumina has entered into an agreement with Amgen to develop and commercialize a multigene, NGS-based test as a companion diagnostic for Vectibix (panitumumab), a fully human anti-EGFR monoclonal antibody therapeutic for the treatment of ...
Tags: Amgen, FDA, CE, Illumina Oncology
Illumina, Inc. (NASDAQ:ILMN) today announced it has entered into a multi-year licensing agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, related to the use of Illumina's ...
Tags: Illumina, multi-year licensing agreement, Quest Diagnostics
Boston Scientific has reported favorable results assessing real-world experience with the Precision Spectra spinal cord stimulator system. New retrospective data highlighting the Boston Scientific Precision Spectra spinal cord stimulator ...
US-based Illumina has obtained premarket clearance from the US Food and Drug Administration (FDA) for the MiSeqDx system, a high-throughput DNA sequencing analyzer. The company has also obtained premarket clearance from the FDA for the ...
Tags: Illumina, MiSeqDx System
US-based Illumina has announced the introduction of its TruGenome undiagnosed disease test provided by Illumina Clinical Services Laboratory (ICSL). Using whole human genome sequencing, the TruGenome test helps clinicians in identifying ...
Tags: Illumina, Undiagnosed Disease Test
Clontech Laboratories, a wholly-owned subsidiary of Takara Bio, announced the launch of the SMARTer Stranded RNA-Seq kit for strand-specific RNA-Seq from low-input RNA samples. The SMARTer Stranded RNA-Seq kit combines Clontech ...
Tags: Clontech Laboratories, RNA-Seq Kit
US-based Illumina has launched its TruSight One Sequencing Panel, a broadest sequencing panel that targets 4,813 genes with known associated clinical phenotypes. Laboratories can use this panel to expand existing menus, streamline ...
Tags: Illumina, Sequencing Panel
HistoGenetics, a New York-based biotech firm specialized in Human Leukocyte Antigen (HLA) typing services and Sequenced-Based Typing (SBT), has selected Illumina's MiSeq sequencing system for use in its CLIA laboratory. Illumina's MiSeq ...
Pathogenica and Illumina have entered into an agreement to co-market a new version of the former’s HAI BioDetection kit in the Asia Pacific region. Currently under development and compatible with Illumina's MiSeq benchtop sequencing ...
Tags: Biodetection Kit, Medicine
Hamilton Robotics has teamed up with Illumina to fully automate the upstream workflow of next-generation sequencing (NGS) sample preparation to lower operational variability and deliver improved as well as consistent results. As part of ...
Tags: Hamilton Robotics, NGS Workflow
Elsevier has collaborated with Illumina to launch Genomics Data app, a sequencing and array-based solutions provider for genetics research. The app enables to share large data sets in Illumina's BaseSpace cloud, where they can easily be ...
Tags: Elsevier, Illumina, Genomics Data App
Takara Bio's subsidiary Clontech Laboratories has released the SMARTer Universal Low Input RNA Kit for sequencing. The kit, which extends the company's next generation sequencing (NGS) solutions, includes low input samples of compromised ...
Tags: Clontech Labs, RNA Kit
GeneInsight and Ingenuity Systems, a biomedical information and genomics analysis provider, will join forces for an integrated workflow solution, covering the annotation, analysis, assessment and reporting of human variants from ...
Tags: biomedical information, genomics analysis, clinical laboratory market